REMICADE® (Johnson & Johnson)
(https://remicade.com) 📸 Data Snapshot: June 19, 2026Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Information density is exceptionally high for a consumer-facing site. Headings like H2 ‘I am CURRENTLY being treated with REMICADE®’ are functional rather than promotional. The body text contains zero power-word fluff, instead providing a granular list of eight specific therapeutic areas including ‘active ankylosing spondylitis’ and ‘chronic severe plaque psoriasis.’ The substance-to-fluff ratio is high due to the clinical specificity of the indications listed.
Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.
📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE (https://remicade.com) Official Consumer Website for REMICADE® (infliximab) | REMICADE®
[H2] I am CURRENTLY being treated with REMICADE® Your treatment choice. Being asked to switch. Support to stay on therapy. Get information [H2] I am starting treatment with REMICADE® Learn about REMICADE®. How REMICADE® works. Paying for therapy. Learn more Adult: moderately to severely active Crohn’s disease Pediatric: moderately to severely active Crohn's disease Adult: moderately to severely active ulcerative colitis Pediatric: moderately to severely active ulcerative colitis Adult: moderately to severely active rheumatoid arthritis Adult: active psoriatic arthritis Adult: active ankylosing spondylitis Adult: chronic severe plaque psoriasis [H2] Patient resources [IMG: Money Icon] Find cost support options to help make treatment more affordable. LEARN ABOUT COST SUPPORT OPTIONS [IMG: Headset Icon] See how our J&J withMe Care Coordinators can help you start, stay, and save on REMICADE®. Customized support from a J&J withMe care coordinator [IMG: Location Icon] See treatment locations that are close to your home or workplace. Find an infusion center [IMG: Magazine Icon] Get more information about REMICADE® and listen to other patients describe their treatment experiences. Resources for you
🧭 Industry Context — common generic-claim patterns in Medical Devices, Pharma & Biotech to weigh the text against
This page presents a snapshot of public data from REMICADE® (Johnson & Johnson), captured on June 19, 2026, to show how machine logic reads Information Density signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to REMICADE® (Johnson & Johnson): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://remicade.com to view the most current version of its content and see directly what this company is about and what it offers.